BeStock  
Stocks › Biotechnology › STOK

Stoke Therapeutics STOK

US equityMarket cap rank #2770Biotechnology
$26.81 −$0.12 (-0.45%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.40 +2.20%
Open$26.39
Prev close$26.93
Day range$25.94 – $27.78
Volume615.8K
Market cap$1.75B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-7.1x
CheapRich

Below its usual level · 23rd percentile, 5-year average -7.3x

Price / book4.9x
CheapRich

Near the top of its 5-year range · 81st percentile, 5-year average 3.2x

#4375 of 5335 stocks by PB (1 = cheapest)

Price / sales61.9x
CheapRich

Above its usual level · 78th percentile, 5-year average 41.8x

#4901 of 5159 stocks by PS (1 = cheapest)

P/E over five years

-327x-190x-53x85xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$45.35
Price vs. fair value-40.9%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 4.95 – 3.15 81% (pricier than usual) #4375 of 5335 (1 = cheapest)
PE -7.06 -5.51 -7.27 23% (cheaper than usual) –
PS 61.86 53.00 41.82 78% (pricier than usual) #4901 of 5159 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on STOK.

Sign in to join the discussion.

Scroll to Top